Can-Fite BioPharma Ltd. (CANF) Stock Price, Latest News, Company Profile & Institutional Holding

#ThinkSabio Latest News

$CANF – Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Light
Dark